These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Half-life time or clearance of indocyanine green in patients with liver disease. Gilmore IT, Marigold JH, Thompson RP. Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884 [Abstract] [Full Text] [Related]
16. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics. Birnie GG, Fitzsimons CP, Czarnecki D, Cooke A, Scobie G, Brodie MJ. Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199 [Abstract] [Full Text] [Related]
17. [Effect of pneumoperitoneum on the liver blood flow in cirrhotic rats]. Xu D, Sun J, Li F, Li D, Liu J, Sun H, Liu S. Zhonghua Wai Ke Za Zhi; 2002 Sep; 40(9):696-8. PubMed ID: 12411144 [Abstract] [Full Text] [Related]
18. Hepatic function and portal hemodynamics in patients with liver cirrhosis. Kawasaki T, Moriyasu F, Kimura T, Someda H, Tamada T, Yamashita Y, Ono S, Kajimura K, Hamato N, Okuma M. Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201 [Abstract] [Full Text] [Related]
19. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis. Mukherjee S, Rogers MA, Buniak B. Hepatogastroenterology; 2006 Sep; 53(67):120-3. PubMed ID: 16506389 [Abstract] [Full Text] [Related]